TREAT TB Events

Wednesday, October 30, 2019 - Saturday, November 2, 2019

Event

Date and Time

Location

Presentation

Experience using tablet technology for detection and monitoring of hearing loss among patients with MDR-TB in the STREAM clinical trial – Ishmael Qawiy

Thursday, 12:45 – 13:45

Hall 3

Evaluation of dissemination of preliminary results from STREAM stage 1 – Samantha Kozikott

Thursday, 12:45 – 13:45

Hall 3

Community engagement in research and development: STREAM experience in building CAB networks  – Oxana Rucsineanu

Thursday, 12:45 – 13:45

Hall 3

Examining the efficacy of the short MDR-TB regimen: alternative analyses from the STREAM trial – Patrick Phillips

Thursday, 16:00-17:30

MR G.05 & G.06

Health workers perception of the shorter regimen in MDR-TB treatment: qualitative evidence from Ethiopia – Laura Rosu

Friday, 10:30 – 12:00

Hall 2

Efficacy of genotype MTBDRsl assay to exclude fluoroquinolone and second-line injectable drug resistant Mycobacterium tuberculosis in a multidrug-resistant tuberculosis clinical trial – Gabriela Torrea

Friday, 10:30 – 12:00

MR 1.03 &1.04

Predictive factors of QT prolongation in  STREAM 1 – Gareth Hughes

Friday, 12:45 – 13:45

Hall 3

TB medicine costs for rifampin-resistant tuberculosis treated with a shorter regimen in a clinical trial setting – Jan Komrska

Friday, 16:00 – 17:30

MR 1.05 & 1.06

Baseline predictors of unfavourable outcome in the short MDR-TB regimen: exploratory analyses from the STREAM trial – Saiam Ahmed

Saturday, 14:00 – 15:30

MR G.05 & G.06

QT prolongation and its evolution over time in STREAM 1 – Gareth Hughes

Saturday, 14:00 – 15:30

Hall 3

View Our Event Coverage On Social Media